Gene Therapy Is There Oversight For Patient Safety Hearing Before The Committee On Health, Education, Labor, And Pensions, U.s. Senate

Witnesses: Paul Gelsinger, father of Jesse Gelsinger, participant in gene therapy; Eric Kast, Norman, OK, on behalf of the Cystic Fibrosis Fdn.; Amy Patterson, Dir., Office of Biotech. Activities, NIH; Jay Siegel, Dir., Office of Therapeutic Res. & Review, FDA; Inder Verma, Prof., Molecular Biology, Lab. of Genetics, the Salk Inst., La Jolla, CA; Leroy Walters, Dir., Kennedy Inst. of Ethics, Georgetown Univ.; H. Stewart Parker, president & CEO, Targeted Genetics Corp., Seattle, WA, on behalf of the Biotech. Industry Org.; Introgen Therapeutics, Inc.; & Vera Hassner Sharav, pres. & cofounder & Adil E. Shamoo, v.p. & cofounder, Citizens for Responsible Care & Research.Frist, Bill is the author of 'Gene Therapy Is There Oversight For Patient Safety Hearing Before The Committee On Health, Education, Labor, And Pensions, U.s. Senate', published 2000 under ISBN 9780756710811 and ISBN 0756710812.